Key Documents
Ronald L. Dalman MD
Academic Appointments
- Professor - Med Center Line, Surgery - Vascular Surgery
- Member, Bio-X
Contact Information
-
Clinical Offices
Vascular Center 300 Pasteur Dr H3642 MC 5642 Stanford, CA 94305 Tel Work (650) 725-5227 Fax (650) 498-6044Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 721-6709Administrative Contact Barbara Munoz Email Tel Work 650-721-6709Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Vascular Surgery
- Aortic Aneurysm
- Limb Salvage
- Aortic Diseases
- Aorta, Abdominal
Administrative Appointments
- Program Director, Vascular Surgery Residency Program, Stanford University School of Medicien (2005 - present)
- Director, Vascular Center, Stanford Hospital and Clinics (2005 - present)
- Professor and Chief, Division of Vascular Surgery, Stanford University School of Medicine (2005 - present)
Honors and Awards
- Chair, Research Council, Society for Vascular Surgery (2008-2010)
- Ad hoc member, Biotechnology and Surgical Sciences Study Section, Center for Scientific Review, NIH (2003-2005)
- President, Silicon Valley Affiliate, American Heart Association (1999-2000)
- Chairman, Membership Committee, Society for Vascular Surgery (2001)
- E. J. Wylie Travelling Fellowship in Vascular Surgery, Lifeline Foundation (2000 -2001)
Professional Education
| Board Certification: | Vascular Surgery, American Board of Surgery (1992) |
| Residency: | Oregon Health Sciences Univ Hospital, OR (1991) |
| Board Certification: | General Surgery, American Board of Surgery (1990) |
| Residency: | University of Washington Medical Center, WA USA (1989) |
| Internship: | U. Washington, (1985) |
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Community & International Work
Web Site Links
Scientific Focus
Research Interests
We are investigating the biologic and mechanical basis of aneurysmal degeneration of the aorta. We use molecular, imaging and computer modeling modalities to identify novel treatment strategies for small AAAs and hybrid drug/device surgical solutions for larger AAAs.
By extension we are keenly interested in new surgical technology and its application to aneurysmal and
occlusive arterial and venous diseases. To this end we have completed over 50 drug and device clinical trials from dozens of governmental and commercial sponsors in our SUMC and VA clinical practices. We are currently enrolling patients in over a dozen clinical trials at both sites. Please review our website (vascular.stanford.edu) for updates regarding clinical trials and eligibility criteria.
Clinical Trials
- Abdominal Aortic Aneurysms: Simple Treatment or Prevention (AAA: STOP) Recruiting
- Abbott Vascular Carotid Stent Systems and Embolic Protection Systems to treat Carotid Artery Stenosis in High Surgical-Risk Patients Recruiting
- Endovascular repair of abdominal aortic aneurysm with angled aorta, angled aneurysmal body or both. Recruiting
- Safety and effectiveness study of Endurant Stent Graft System as endovascular treatment of infrarenal abdominal aortic or aortoiliac aneurysms. Recruiting
- Stenting procedure with distal protection in the treatment of obstructive carotid artery disease in high-surgical risk patients with atherosclerotic disease of the carotid artery(ies) Recruiting
Publications
- Identifying abdominal aortic aneurysm risk factors in postmenopausal women. Womens Health (Lond Engl). 2009; (1): 33-7
- Reduction of postprocedure microemboli following retrospective quality assessment and practice improvement measures for carotid angioplasty and stenting. J Vasc Surg. 2009; (3): 607-12; discussion 612-3
- Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. Am J Physiol Heart Circ Physiol. 2009; (5): H1329-35
- Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression. Arterioscler Thromb Vasc Biol. 2009; (10): 1452-7
- Preoperative thrombus volume predicts sac regression after endovascular aneurysm repair. J Endovasc Ther. 2009; (3): 380-8

